Skip to content

Workshop 2: Assessment and clinical importance of pharmacist recommendations

Room:

J2

Facilitator:

Ulrika Gillespie

Speakers:

Abstract:

Linked to EAHP Statements

Section 4 – Clinical Pharmacy Services: Statements 4.1, 4.3, 4.8
Section 5 – Patient Safety and Quality Assurance: Statement 5.2
Section 6 – Education and Research: Statements 6.2, 6.3

ACPE UAN: 0475-0000-18-028-L04-P. An application based activity.

Abstract

In order to optimise drug therapy in inpatients, it is important to develop a systematic and integrated approach to the management of medications from the time of admission, during the hospital stay and at discharge. Pharmacists, performing medication reviews in a multi-professional team, must be able to prioritise which drug related problems (DRPs) to focus on to ensure that patient harm is avoided and treatment goals reached.

The clinical relevance of the interventions initiated by pharmacists has been investigated previously using different tools for assessment. For example, Hatoum et al. used a ranking system that focused on the value of the service by assessing the potential impact of pharmacists’ recommendations.

In this workshop, several real patient cases will be presented; each together with one isolated DRP and recommendation for solution. The recommendations have all been assessed previously by experts using a validated tool for the classification of importance. The participants will assess the importance individually (using a voting system) and the results will be compared to the experts’ opinion and discussed in plenum.

Learning objectives

  • Describe approaches to assess the clinical significance of pharmacists’ recommendations (arising from drug related problems)
  • Reflect on the clinical significance of recommendations in their own setting, using patient cases in group discussions with colleagues for educational purposes

Educational need addressed

Pharmacists are still relatively new members of multidisciplinary teams. When performing medication reviews and identifying drug related problems (DRPs), they will need to be able to prioritise and focus on resolving those issues that are most relevant to the patient at that time.

Keywords: assessing clinical significance, pharmacists’ recommendations, drug related problems

Handouts: Ulrika Gillespie and Henrik Toss

×

Join us in Prague at the special rate of
350 Euro*(+ 21% Czech VAT)
to promote
WORLD PHARMACIST DAY 2025!

Secure your spot (only 45 seats available!)

*instead of 400 Euro – Offer available from 25/09 at 00h01 to 30/09 at 23h59 CET

×

Join us in Prague for

the 2nd edition of BOOST!

Secure your spot (limited seats available!)

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy — the shortage of medicine and medical devices.

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.